Topchoice Medical shareholders approve governance revisions, abolish supervisory board

Topchoice Medical Corporation held its first extraordinary general meeting of shareholders in 2025 on December 10, 2025, in Hangzhou. The meeting, attended by 543 shareholders and proxies representing 163,135,995 shares or 36.4721% of total voting shares, resulted in the unanimous passage of all submitted proposals. These included revisions to the articles of association, shareholder meeting rules, board of directors meeting rules, and independent director work system.

Key approvals also covered amendments to the external investment management system, connected transaction decision-making system, and the system for preventing controlling shareholders and related parties from occupying company funds. The resolution concerning the cancellation of the supervisory board and the removal of supervisors also passed with significant support, receiving 162,644,254 votes in favor (99.6985%).

All resolutions, including those related to the accountant selection system and the remuneration management system for directors and senior management, were adopted through non-cumulative voting. The meeting's procedures and outcomes were validated by Zhejiang Tiance Law Firm, confirming their compliance with legal, regulatory, and company charter requirements.